• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of molmedLink to Publisher's site
Mol Med. Nov 1994; 1(1): 7–18.
PMCID: PMC2229935

Role of macrophage oxidative burst in the action of anthrax lethal toxin.

Abstract

BACKGROUND: Major symptoms and death from systemic Bacillus anthracis infections are mediated by the action of the pathogen's lethal toxin on host macrophages. High levels of the toxin are cytolytic to macrophages, whereas low levels stimulate these cells to produce cytokines (interleukin-1 beta and tumor necrosis factor-alpha), which induce systemic shock and death. MATERIALS AND METHODS: Experiments were performed to assess the possibility that the oxidative burst may be involved in one or both of lethal toxin's effects on macrophages. Toximediated cell lysis, superoxide anion and cytokine production were measured. Effects of antioxidants and macrophage mutations were examined. RESULTS: RAW264.7 murine macrophages treated with high levels of toxin released large amounts of superoxide anion, beginning at about 1 hr, which correlates with the onset of cytolysis. Cytolysis could be blocked with various exogenous antioxidants or with N-acetyl-L-cysteine and methionine, which promote production of the endogenous antioxidant, glutathione. Mutant murine macrophage lines deficient in production of reactive oxygen intermediates (ROIs) were relatively insensitive to the lytic effects of the toxin, whereas a line with increased oxidative burst potential showed elevated sensitivity. Also, cultured blood monocyte-derived macrophages from a patient with Chronic Granulomatous Disease, a disorder in which the phagocyte's oxidative burst is disabled, were totally resistant to toxin, in contrast to control monocytes. CONCLUSIONS: These results imply that the cytolytic effect of the toxin is mediated by ROIs. Additionally, cytokine production and consequent pathologies showed partial dependence on macrophage ROIs. Antioxidants moderately inhibited toxin-induced cytokine production in vitro, and BALB/c mice pretreated with N-acetyl-L-cysteine or mepacrine showed partial protection against lethal toxin. Thus ROIs are involved in both the cytolytic action of anthrax lethal toxin and the overall pathologic process in vivo.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.7M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Leppla SH. Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryotic cells. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;17:189–198. [PubMed]
  • Cataldi A, Labruyère E, Mock M. Construction and characterization of a protective antigen-deficient Bacillus anthracis strain. Mol Microbiol. 1990 Jul;4(7):1111–1117. [PubMed]
  • Pezard C, Berche P, Mock M. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect Immun. 1991 Oct;59(10):3472–3477. [PMC free article] [PubMed]
  • Friedlander AM. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J Biol Chem. 1986 Jun 5;261(16):7123–7126. [PubMed]
  • Hanna PC, Acosta D, Collier RJ. On the role of macrophages in anthrax. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10198–10201. [PMC free article] [PubMed]
  • Hanna PC, Kochi S, Collier RJ. Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells. Mol Biol Cell. 1992 Nov;3(11):1269–1277. [PMC free article] [PubMed]
  • Leppla SH. Production and purification of anthrax toxin. Methods Enzymol. 1988;165:103–116. [PubMed]
  • Tanaka Y, Kiyotaki C, Tanowitz H, Bloom BR. Reconstitution of a variant macrophage cell line defective in oxygen metabolism with a H2O2-generating system. Proc Natl Acad Sci U S A. 1982 Apr;79(8):2584–2588. [PMC free article] [PubMed]
  • Damiani G, Kiyotaki C, Soeller W, Sasada M, Peisach J, Bloom BR. Macrophage variants in oxygen metabolism. J Exp Med. 1980 Oct 1;152(4):808–822. [PMC free article] [PubMed]
  • Johnston RB., Jr Measurement of O2- secreted by monocytes and macrophages. Methods Enzymol. 1984;105:365–369. [PubMed]
  • Markert M, Andrews PC, Babior BM. Measurement of O2- production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils. Methods Enzymol. 1984;105:358–365. [PubMed]
  • Griffith OW. Depletion of glutathione by inhibition of biosynthesis. Methods Enzymol. 1981;77:59–63. [PubMed]
  • Singh Y, Leppla SH, Bhatnagar R, Friedlander AM. Internalization and processing of Bacillus anthracis lethal toxin by toxin-sensitive and -resistant cells. J Biol Chem. 1989 Jul 5;264(19):11099–11102. [PubMed]
  • Scott P, James S, Sher A. The respiratory burst is not required for killing of intracellular and extracellular parasites by a lymphokine-activated macrophage cell line. Eur J Immunol. 1985 Jun;15(6):553–558. [PubMed]
  • Ezekowitz RA. Chronic granulomatous disease: an update and a paradigm for the use of interferon-gamma as adjunct immunotherapy in infectious diseases. Curr Top Microbiol Immunol. 1992;181:283–292. [PubMed]
  • Fawthrop DJ, Boobis AR, Davies DS. Mechanisms of cell death. Arch Toxicol. 1991;65(6):437–444. [PubMed]
  • Wright GG, Mandell GL. Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and by muramyl dipeptide. J Exp Med. 1986 Nov 1;164(5):1700–1709. [PMC free article] [PubMed]
  • O'Brien J, Friedlander A, Dreier T, Ezzell J, Leppla S. Effects of anthrax toxin components on human neutrophils. Infect Immun. 1985 Jan;47(1):306–310. [PMC free article] [PubMed]
  • Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991 Aug;10(8):2247–2258. [PMC free article] [PubMed]
  • Lenardo MJ, Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell. 1989 Jul 28;58(2):227–229. [PubMed]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...